Table of Contents
August 2015 Supplement
The Evolution of SFA Care: The DCB Paradigm Shift
An in-depth look at how the science and clinical use of the first FDA-approved drug-coated balloon, LUTONIX® 035, continues to advance the treatment of PAD.
Sponsored by Bard Peripheral Vascular, Inc.
In This Supplement